Top Banner
Lecture 19 Past, Present & Future Vaccines
27

Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Jun 25, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Lecture 19

Past, Present & FutureVaccines

Page 2: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

The Lecture in a Single Slide

• Vaccines Have Been Used Since At Least the Beginning of the 19th

Century

• While Understanding about Infectious Agents and Vaccines Has Improved Dramatically, the Breadth of Agents Targeted with Vaccines Has Not Kept Pace

• The Anti-Vaccine Movement Foreshadowed the Return of Avoidable Childhood Diseases

Page 3: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

A Glimpse From the Past:Smallpox

• Rates of Smallpox death in London documented since 1629• At its peak, 170 deaths (per 1,000 people) until 1800• Rapid decline thereafter• Why the decline?

Page 4: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Sanitation

• John Snow*• Mapped 1854 cholera deaths

to identify responsible wells

• Not believed & broke pump handle

• Founder or Epidemiology

• Hygiene improvements affected other diseases

Page 5: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Return to Smallpox

• Despite centuries of experience, the actual cause of death from smallpox remains largely unknown

• Respiratory transmission causes greatest viremia and death

Page 6: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Variolation

• Variolation• China: Nasal insufflation – Powdered scabs• Sudan: Cloth transferred from infected to

uninfected person’s arm; pustule contents into cut

• Introduced into UK by Lady Montagu and US by Cotton Mather

Lady Montagu Cotton Mather

Page 7: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Variolation to Inoculation

• Conventional Wisdom

• Gloucestershire doctor• mid-1796: Edward Jenner realizes

milkmaids resistant to smallpox• Immunizes James Phipps (8 yo boy)

with cowpox from “Blossom”

• 1774: Benjamin Jesty inoculates

wife & children with cowpox

• Did not publish data• John Fewster (1765) & Jobst Bose

(1769) correlate cowpox infection

with smallpox protection

Benjamin Jesty

EdwardJenner

Page 8: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Smallpox Eradication

• Smallpox lack non-human vectors• Global immunization• 1840: British Vaccination Act

• Mandatory vaccination, forbad variolation• 1843-1850: US States passed similar

laws• 1950: Pan American goal of smallpox

elimination from Western hemisphere• 1967: WHO worldwide effort• 1975: Last naturally occuring case

(Rahima Banu from Bangladesh)Rahima Banu

Directors of CDC Smallpox Eradication Program

Donald Millar, William Foege, Michael Lane

Page 9: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Well, Kind of (not really) Eradicated

• US & Soviet Union Agreed to Keep Smallpox vials for “defensive” use (future vaccines)

• Old samples periodically unearthed

• Soviets (& Russians) continued developing smallpox-based weapons

Page 10: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Growth in Immunotherapy

• Vaccine Growth in Parallel with Understanding of Disease & Immune Function

• FDA Approved 119 Different Immunotherapies (as of 2016)

• Major Trends:• Passive vs. Active• Live vs. Dead Vaccines• Diseases Targeted• Prophylaxis vs. Therapeutic

0

20

40

60

80

100

120

Through

1900

1901-1

910

1911-1

920

1921-1

930

1931-1

940

1941-1

950

1951-1

960

1961-1

970

1971-1

980

1981-1

990

1991-2

000

2001-2

010

2011-2

015

Cum

ulat

ive

Imm

unot

hera

pies

Passive

Active

Page 11: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

A Quick Word on Passive Immunotherapy

• Concept: Transfer pre-existing immunity in human or non-human sources to patients

• Applications:• When quick immune defense is

needed• Animal Bites: Snakes, spiders, etc• Infectious Diseases: viral and

bacterial

Page 12: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Live vs. Dead Vaccines

• Dead Vaccines - Proteins, inactivated• Advantages:

• Low risk of infection• Target immune response towards epitopes

• Disadvantages: • Fewer epitopes • Incomplete inactivation

• Live Vaccines - Attenuated• Advantages:

• More epitopes• Physiological relevance

• Disadvantages• Potential for damage (immunosuppressed)• Manufacturing can be challenging

Page 13: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Poliomyelitis

• Old disease, traced back to Egypt• Ingested through mouth• Causes CNS paralysis, spinal damage

• Generally, not as dangerous if exposed at young age

• Improvements in santiation & hygiene delayed exposure• More severe disease in teens & adults

Alan Alda

Arthur C Clarke

Itzhak Perlman

Patrick PlayfairLaidlaw

Page 14: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Incapacitating Fear of Polio

• Debilitating fear of disease

• Spread in Summer• Parks and pools would close• People cautioned not to vacation (or

where to vacation)

• Schools Closed • Start Late in Season

Page 15: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Salk Vaccine

• Early vaccine attempts largely failed

• Breakthrough from virus propagation in

tissue culture (John Enders, Thomas

Weller, Frederick Robbins)

• Jonas Salk (Univ. Michigan) under

Thomas Francis before own lab at Univ

of Pittsburgh

• Developed killed version of polio• Clinical tests starting in 1953• Reported activity (13 Apr 1955)

Page 16: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

The Cutter Incident

• Cutter Laboratories (1955)• Company did not fully inactivate virus

• 40,000 cases of polio• 200 cases of paralysis• 10 deaths

• Salk’s Enemies Pounced• No Nobel prize• Sabin vaccine accelerated

Page 17: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Sabin Vaccine

• Attenuated Poliovirus developed by Albert Sabin• University of Cincinnati

• Virus passaged through animals to weaken its activity against humans

• Oral administration (via sugar cube)

Page 18: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Live versus Dead Vaccines

• “Dead” or subunit antigens capture majority of faccines

• Ratio has remained at roughly 3:1 through history

0

2

4

6

8

10

12

Through

1900

1901-1

910

1911-1

920

1921-1

930

1931-1

940

1941-1

950

1951-1

960

1961-1

970

1971-1

980

1981-1

990

1991-2

000

2001-2

010

2011-2

015

Vacc

ines

App

rove

d

Live

Dead

Page 19: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Vaccine-Preventable Diseases

• Virus and Bacterial Diseases Targeted by Vaccines• Relative ratio has remained

remarkably steady since 1950s

• Neurologic, respiratory and gastrointestinal indications capture most vaccines

0

2

4

6

8

10

12

Through 1900

1901-1910

1911-1920

1921-1930

1931-1940

1941-1950

1951-1960

1961-1970

1971-1980

1981-1990

1991-2000

2001-2010

2011-2015

Vacc

ine

Appr

oval

s

VirusBacteriumCancer

0

2

4

6

8

10

12

Through 1900

1901-1910

1911-1920

1921-1930

1931-1940

1941-1950

1951-1960

1961-1970

1971-1980

1981-1990

1991-2000

2001-2010

2011-2015

Vacc

ine

Appr

oval

s

Nervous SystemRespiratoryGastrointestinalOther

Page 20: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Killed Influenza Vaccine

• Developed by Thomas Francis, Jr, Jonas Salk and others

• Influenza Virus incoluated into allantoic cavity of eggs• Working seed bank developed (month 2)• Cell culture methods approved

• Utilized virus grown and killed • Formalin or beta-propiolactone• Reagents standardized• Filling, safety release

Page 21: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Influenza Virus Vaccine Cycle Northern Hemisphere

• February: • WHO recommends influenza

strains for next year• Three strains selected for

trivalent vaccine

• FDA provides seed strains to manufacturers• Goal: Final product testing

by 1 Aug• Final approval by or in Sept http://www.nature.com/news/2009/090512/full/459144a/box/1.html

Page 22: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Breadth of Application

• The net number of infectious diseases targeted has remained steady since 1981

• Most advancements have arisen from improvements of existing vaccines

-1

0

1

2

3

4

5

Before…

1901-1

910

1911-1

920

1921-1

930

1931-1

940

1941-1

950

1951-1

960

1961-1

970

1971-1

980

1981-1

990

1991-2

000

2001-2

010

2011-2

015

Indi

catio

ns T

arge

ted

0

5

10

15

20

25

Before 1900

1901-1

910

1911-1

920

1921-1

930

1931-1

940

1941-1

950

1951-1

960

1961-1

970

1971-1

980

1981-1

990

1991-2

000

2001-2

010

2011-2

015

Infe

ctio

us D

iseas

es (N

et)

Page 23: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Vaccine Withdrawals

• Most vaccines withdrawn due to Obsolescence (replacement by a superior product)

• Remarkably few withdrawn due to toxicity Obsolescence, 41

Efficacy, 5

Toxicity, 2Market, 3

Page 24: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

What Evidence Links Vaccines to Autism?

Page 25: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Vaccine Deniers

• Anti-vaccine movement

• Provoked by scandalous report linking vaccines to autism• Suggested link with thimerosol (mercury)

preservatives• Andrew Wakefield study thoroughly

discredited

• Movement surprisingly active

amongst educated Americans

• Increasing US incidence of measles, whooping cough, other preventable infections Council on Foreign Relations

MeaslesWhooping cough

Page 26: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

Vaccines for Cancer:

• Gardasil Approved for Prevention of HPV infection• Linked to cervical and other cancer

• Virus Like Particle (VLP) that self-assembles into a virion lacking nucleic acid

• Other Cancer Vaccines the Subject of Next Lecture http://www.discoverymedicine.com/Richard-Roden/files/2009/08/roden_35_fig2.jpg.jhtml?id=2

Page 27: Lecture 19...Vaccine-Preventable Diseases •Virus and Bacterial Diseases Targeted by Vaccines •Relative ratiohas remained remarkably steady since 1950s •Neurologic, respiratoryand

The Lecture in a Single Slide

• Vaccines Have Been Used Since At Least the Beginning of the 19th

Century

• While Understanding about Infectious Agents and Vaccines Has Improved Dramatically, the Breadth of Agents Targeted with Vaccines Has Not Kept Pace

• The Anti-Vaccine Movement Foreshadowed the Return of Avoidable Childhood Diseases